Other Briefings
India’s New GDP Series (Base Year 2022-23): Structural Recalibration for Businesses & Investors
India’s new GDP series (base year 2022-23) modernizes economic measurement. This structural recalibration offers investors and businesses deeper sectoral insights and a more accurate reflection of India’s growth trajectory.
India and Brazil Target US$30 Billion Trade by 2030: Strategic Partnership Expands Across Minerals, Tech, and Healthcare
India and Brazil plan to double bilateral trade to US$30 billion by 2030, expanding cooperation across critical minerals, digital technology, healthcare, and supply chains.
US Tariff Twists: Where Does India Stand and How Will Exporters Get Impacted?
With the US Supreme Court tariff ruling, followed by new solar import duties of 125.87 percent on Indian exporters, India-US trade dynamics are being reshaped, prompting exporters and investors to reassess pricing strategies, supply chains, and tariff risk exposure.
India’s Next Growth Cycle: Sector Intelligence for Scalable Market Entry
From sector entry considerations to market localization, compliance planning, and export optimization, this magazine provides a practical roadmap for scalable, long-cycle investment in India.
Europe’s India Pivot: Ports, Missiles, and AI
In this op-ed, we discuss how Europe appears to be deepening its engagement with India across maritime connectivity, defense co-production, and AI innovation and governance. A cluster of leadership visits and industrial agreements following the conclusion of the India–EU FTA signals a structural alignment rather than temporary diplomatic momentum.
Modi and Macron Elevate India-France Ties to ‘Special Global Strategic Partnership’
On February 17, 2026, India’s prime minister and the French president announced the Special Global Strategic Partnership, formalizing deeper defense, aerospace, and advanced technology integration. For foreign firms and investors, the framework enhances policy predictability and long-term industrial and investment alignment.
India’s Orange Economy: Creative Industries Outlook After Budget 2026
As of 2026, India’s orange economy is emerging as a high-growth services opportunity, spanning media, live concerts, AVGC, and creative industries, supported by policy reform.
India Fast-Tracks New Drug & Clinical Trial Approvals with 2026 NDCT Amendments
India’s 2026 amendments to the New Drug and Clinical Trials (NDCT) Rules, 2019, materially improve the operating environment for pharmaceutical companies, contract manufacturers, and foreign investors by compressing approval timelines and reducing pre-licensing bottlenecks.
